![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 2
Zeitschriftenartikel
Rejeski, Kai 
ORCID: https://orcid.org/0000-0003-3905-0251; Wang, Yucai ORCID: https://orcid.org/0000-0002-1576-8341; Albanyan, Omar; Munoz, Javier; Sesques, Pierre ORCID: https://orcid.org/0000-0001-8264-822X; Iacoboni, Gloria; Lopez‐Corral, Lucia; Ries, Isabelle; Bücklein, Veit L.; Mohty, Razan; Dreyling, Martin; Baluch, Aliyah; Shah, Bijal ORCID: https://orcid.org/0000-0003-4328-6021; Locke, Frederick L.; Hess, Georg; Barba, Pere; Bachy, Emmanuel; Lin, Yi; Subklewe, Marion ORCID: https://orcid.org/0000-0001-9154-9469 und Jain, Michael D. ORCID: https://orcid.org/0000-0002-7789-1257
(2023):
The CAR‐HEMATOTOX score identifies patients at high risk for hematological toxicity, infectious complications, and poor treatment outcomes following brexucabtagene autoleucel for relapsed or refractory MCL.
In: American Journal of Hematology, Bd. 98, Nr. 11: S. 1699-1710
[PDF, 2MB]
ORCID: https://orcid.org/0000-0003-3905-0251; Wang, Yucai ORCID: https://orcid.org/0000-0002-1576-8341; Albanyan, Omar; Munoz, Javier; Sesques, Pierre ORCID: https://orcid.org/0000-0001-8264-822X; Iacoboni, Gloria; Lopez‐Corral, Lucia; Ries, Isabelle; Bücklein, Veit L.; Mohty, Razan; Dreyling, Martin; Baluch, Aliyah; Shah, Bijal ORCID: https://orcid.org/0000-0003-4328-6021; Locke, Frederick L.; Hess, Georg; Barba, Pere; Bachy, Emmanuel; Lin, Yi; Subklewe, Marion ORCID: https://orcid.org/0000-0001-9154-9469 und Jain, Michael D. ORCID: https://orcid.org/0000-0002-7789-1257
(2023):
The CAR‐HEMATOTOX score identifies patients at high risk for hematological toxicity, infectious complications, and poor treatment outcomes following brexucabtagene autoleucel for relapsed or refractory MCL.
In: American Journal of Hematology, Bd. 98, Nr. 11: S. 1699-1710
[PDF, 2MB]
Dreyling, Martin; Santoro, Armando; Mollica, Luigina; Leppä, Sirpa; Follows, George; Lenz, Georg; Kim, Won Seog; Nagler, Arnon; Dimou, Maria; Demeter, Judit; Özcan, Muhit; Kosinova, Marina; Bouabdallah, Krimo; Morschhauser, Franck; Stevens, Don A.; Trevarthen, David; Munoz, Javier; Rodrigues, Liana; Hiemeyer, Florian; Miriyala, Ashok; Garcia‐Vargas, Jose; Childs, Barrett H. und Zinzani, Pier Luigi
(2020):
Long‐term safety and efficacy of the PI3K inhibitor copanlisib in patients with relapsed or refractory indolent lymphoma: 2‐year follow‐up of the CHRONOS‐1 study.
In: American Journal of Hematology, Bd. 95, Nr. 4: S. 362-371
[PDF, 1MB]